Over the last 12 months, NovoCure insiders reported no purchases and 8 sales totaling $940K across SEC Form 4 filings.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Leonard Frank XChief Executive Officer · O | ▼ Sale | 34,273 | $17.93 | $615K | -6.9% | — |
| Jun 2, 2026 | LEUNG GABRIELD | ▼ Sale | 2,945 | $15.77 | $46K | -3.2% | — |
| Jun 2, 2026 | Stafford KristinD | ▼ Sale | 2,945 | $15.77 | $46K | -20.6% | — |
| Jun 2, 2026 | Ocean Allyson JD | ▼ Sale | 2,945 | $15.77 | $46K | -20.6% | — |
| Jun 2, 2026 | Scannell Timothy JD | ▼ Sale | 2,945 | $15.77 | $46K | -17.1% | — |
| Jun 2, 2026 | HILLEMAN JERYL LD | ▼ Sale | 2,945 | $15.77 | $46K | -17.5% | — |
| Jun 2, 2026 | VERNON W ANTHONYD | ▼ Sale | 2,945 | $15.77 | $46K | -1.5% | — |
| Jun 2, 2026 | Hung DavidD | ▼ Sale | 2,945 | $15.77 | $46K | -12.6% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $NVCR feed.